leisure time -WSS

leisure time

author：explore 2025-10-01 15:39:33 - browse：6944

An army of wooden figures under blue and pink lighting — biotech coverage from STAT — Adobe

In an abrupt change of course from plans earlier in the month, at-home test maker Cue Health is laying off all of its employees and shutting down as of Friday, May 24.

The company, which grew to prominence during the Covid-19 pandemic as the maker of one of the only molecular at-home tests for the virus, has been teetering on the edge of insolvency for months. The shutdown, first reported by the San Diego Union-Tribune, comes just over a week after the FDA warned consumers not to use Cue’s only FDA-authorized product, a Covid-19 test kit.

Cue had previously notified 49% of its workers on May 1 that they would be laid off from the company, effective July 1. But in a WARN notice filed with California state regulators on May 20, chief human resources officer Allison Blackwell said that due to the “fluid nature of this situation,” all U.S. employees who had not already received notice of termination would be receiving one. All employees will receive their last paychecks on May 24, the notice said.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： In Memoriam: Notable people who died in 2023
Next article： Teladoc has a new CEO, but challenges remain the same

hotspot

WSS

Stephen Quake on the Chan Zuckerberg quest to conquer disease

Humana’s losses in Medicare Advantage tank its stock

Lilly's Alzheimer's drug donanemab backed by FDA advisers

Reconstructing family trees of blood cells may help predict disease

California wildfire smoke linked to 52,000 early deaths, study says

Coercive sterilizations revealed by STAT prompt outrage

hotspot

leisure time

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

Wikipedia

In Memoriam: Notable people who died in 2023

Statins may not be needed by millions of people, study suggests

As demand for Covid shots wanes, Moderna seeks its next success

5 takeaways from STAT's examination of Zynex Medical

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Merck CEO won’t testify in Senate, citing no expertise in drug prices

Alkermes shareholders re

Report captures long Covid’s disabling effects and policy challenges

Heart attack and stroke risk calculators need revising

Zyn nicotine pouches become unlikely player in latest culture war

hotspot

Pancreatic cancer early detection could be helped by AI

Report captures long Covid’s disabling effects and policy challenges

Deposition: Sackler embraced plan to conceal OxyContin’s strength

Readers discuss the intersection of pregnancy and addiction

STAT Virtual Event: ASCO Recap, Live!

Vertex non

hotspot

hotspot

focus

entertainment